Diabetes mellitus and severe mental illness: mechanisms and clinical implications
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diabetes mellitus and severe mental illness: mechanisms and clinical implications
Authors
Keywords
-
Journal
Nature Reviews Endocrinology
Volume 11, Issue 2, Pages 79-89
Publisher
Springer Nature
Online
2014-12-02
DOI
10.1038/nrendo.2014.203
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening for Metabolic Syndrome in Older Patients with Severe Mental Illness
- (2014) Hugo W. Konz et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Serum Vitamin D Levels in Relation to Schizophrenia: A Systematic Review and Meta-Analysis of Observational Studies
- (2014) Ghazaleh Valipour et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of Vitamin D3Supplementation on Improving Glucose Homeostasis and Preventing Diabetes: A Systematic Review and Meta-Analysis
- (2014) Jennifer C. Seida et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Quetiapine Treatment in Youth Is Associated With Decreased Insulin Secretion
- (2014) Ying Fai Ngai et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis
- (2014) Maarten Bak et al. PLoS One
- Long-term mortality of persons with severe mental illness and diabetes: a population-based cohort study in Denmark
- (2014) A. R. Ribe et al. PSYCHOLOGICAL MEDICINE
- Pharmacological Strategies to Counteract Antipsychotic-Induced Weight Gain and Metabolic Adverse Effects in Schizophrenia: A Systematic Review and Meta-analysis
- (2014) Y. Mizuno et al. SCHIZOPHRENIA BULLETIN
- Identifying aspects of neighbourhood deprivation associated with increased incidence of schizophrenia
- (2014) Vishal Bhavsar et al. SCHIZOPHRENIA RESEARCH
- Molecular pathophysiology of metabolic effects of antipsychotic medications
- (2014) Jacob S. Ballon et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial
- (2014) Julie Rask Larsen et al. BMJ Open
- Diabetes Risk Potentially Underestimated in Youth and Children Receiving Antipsychotics
- (2014) Katherine Samaras et al. JAMA Psychiatry
- Metabolic Syndrome and Metabolic Abnormalities in Bipolar Disorder: A Meta-Analysis of Prevalence Rates and Moderators
- (2013) Davy Vancampfort et al. AMERICAN JOURNAL OF PSYCHIATRY
- Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force
- (2013) Susan L. Norris et al. ANNALS OF INTERNAL MEDICINE
- Inflammatory Cytokines and Neurological and Neurocognitive Alterations in the Course of Schizophrenia
- (2013) Anna M. Fineberg et al. BIOLOGICAL PSYCHIATRY
- Lack of association between a functional variant of the BRCA-1 related associated protein (BRAP) gene and ischemic stroke
- (2013) Yi-Chu Liao et al. BMC Medical Genetics
- Standards of Medical Care in Diabetes--2014
- (2013) DIABETES CARE
- The effects of antipsychotic switching on diabetes in chronic schizophrenia
- (2013) R. Arnoldy et al. DIABETIC MEDICINE
- Genetics of antipsychotic-induced weight gain: update and current perspectives
- (2013) Amy CC Kao et al. PHARMACOGENOMICS
- Screening for Metabolic Risk Among Patients With Severe Mental Illness and Diabetes: A National Comparison
- (2013) Alex J. Mitchell et al. PSYCHIATRIC SERVICES
- A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls
- (2013) Davy Vancampfort et al. World Psychiatry
- Antipsychotics and the Risk of Type 2 Diabetes Mellitus in Children and Youth
- (2013) William V. Bobo et al. JAMA Psychiatry
- Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar Disorder
- (2012) Marc De Hert et al. CNS DRUGS
- Identifying risk and preventing progression to Type 2 diabetes in vulnerable and disadvantaged adults: a pragmatic review
- (2012) J. Taylor et al. DIABETIC MEDICINE
- The heart of the matter: cardiometabolic care in youth with psychosis
- (2012) Jackie Curtis et al. Early Intervention in Psychiatry
- Is the Prevalence of Metabolic Syndrome and Metabolic Abnormalities Increased in Early Schizophrenia? A Comparative Meta-Analysis of First Episode, Untreated and Treated Patients
- (2012) A. J. Mitchell et al. SCHIZOPHRENIA BULLETIN
- Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: A meta-analytic comparison of randomized controlled trials
- (2012) Jacqueline Caemmerer et al. SCHIZOPHRENIA RESEARCH
- Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone
- (2012) Peter Manu et al. SCHIZOPHRENIA RESEARCH
- Vitamin D and type 2 diabetes: a systematic review
- (2011) J Mitri et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
- (2011) Marc De Hert et al. Nature Reviews Endocrinology
- Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices
- (2011) A. J. Mitchell et al. PSYCHOLOGICAL MEDICINE
- Association of Psychiatric Illness and Obesity, Physical Inactivity, and Smoking among a National Sample of Veterans
- (2011) Lydia A. Chwastiak et al. PSYCHOSOMATICS
- Twenty-five year mortality of a community cohort with schizophrenia
- (2010) Steve Brown et al. BRITISH JOURNAL OF PSYCHIATRY
- Risk of Acute Complications of Diabetes Among People With Schizophrenia in Ontario, Canada
- (2010) T. Becker et al. DIABETES CARE
- Disruption of the Dopamine D2 Receptor Impairs Insulin Secretion and Causes Glucose Intolerance
- (2010) Isabel García-Tornadú et al. ENDOCRINOLOGY
- Receipt of preventive medical care and medical screening for patients with mental illness: a comparative analysis
- (2010) Oliver Lord et al. GENERAL HOSPITAL PSYCHIATRY
- Intentional Weight Loss in Overweight and Obese Patients With Severe Mental Illness
- (2010) Richard I. G. Holt et al. JOURNAL OF CLINICAL PSYCHIATRY
- Review: A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortality
- (2010) Andrew J Bradley et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Review: Clock genes at the heart of depression
- (2010) David J Kennaway JOURNAL OF PSYCHOPHARMACOLOGY
- Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-Analysis
- (2010) Lawrence Maayan et al. NEUROPSYCHOPHARMACOLOGY
- Environmental correlates of physical activity and dietary behaviours among young people: a systematic review of reviews
- (2010) E. de Vet et al. Obesity Reviews
- Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis
- (2010) Christine Rummel-Kluge et al. SCHIZOPHRENIA RESEARCH
- Rethinking the genetic basis for comorbidity of schizophrenia and type 2 diabetes
- (2010) P.I. Lin et al. SCHIZOPHRENIA RESEARCH
- Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies
- (2009) Alex J. Mitchell et al. BRITISH JOURNAL OF PSYCHIATRY
- Antipsychotic-Induced Weight Gain in Chronic and First-Episode Psychotic Disorders
- (2009) Mario Álvarez-Jiménez et al. CNS DRUGS
- Metabolic Screening After the American Diabetes Association's Consensus Statement on Antipsychotic Drugs and Diabetes
- (2009) E. H. Morrato et al. DIABETES CARE
- Obesity, serious mental illness and antipsychotic drugs
- (2009) Richard I. G. Holt et al. DIABETES OBESITY & METABOLISM
- How can antipsychotics cause diabetes mellitus? Insights based on receptor-binding profiles, humoral factors and transporter proteins
- (2009) F.C.J. Starrenburg et al. EUROPEAN PSYCHIATRY
- Cardiovascular disease and diabetes in people with severe mental illness position statement from the European Psychiatric Association (EPA), supported by the European Association for the Study of Diabetes (EASD) and the European Society of Cardiology (ESC)
- (2009) M. De Hert et al. EUROPEAN PSYCHIATRY
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
- (2009) Christoph U. Correll JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Orlistat in Clozapine- or Olanzapine-Treated Patients With Overweight or Obesity
- (2009) Grigori Joffe et al. JOURNAL OF CLINICAL PSYCHIATRY
- 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
- (2009) Jari Tiihonen et al. LANCET
- Early life predictors of the physiological stress response later in life
- (2009) Eero Kajantie et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Fetal growth restriction and the development of major depression
- (2008) H.-M. Vasiliadis et al. ACTA PSYCHIATRICA SCANDINAVICA
- Diabetes and schizophrenia – effect of disease or drug? Results from a randomized, double-blind, controlled prospective study in first-episode schizophrenia
- (2008) S. Saddichha et al. ACTA PSYCHIATRICA SCANDINAVICA
- Antipsychotics and Diabetes: An Age-Related Association
- (2008) Ariel Hammerman et al. ANNALS OF PHARMACOTHERAPY
- First- v. second-generation antipsychotics and risk for diabetes in schizophrenia: Systematic review and meta-analysis
- (2008) M. Smith et al. BRITISH JOURNAL OF PSYCHIATRY
- Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
- (2008) J. McGrath et al. EPIDEMIOLOGIC REVIEWS
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition
- (2008) M. Kvajo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder: A 12-month follow up
- (2008) Chih-Ken Chen et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: A retrospective chart review
- (2008) Marc De Hert et al. SCHIZOPHRENIA RESEARCH
- Early treatment-related changes in diabetes and cardiovascular disease risk markers in first episode psychosis subjects
- (2008) Karen A. Graham et al. SCHIZOPHRENIA RESEARCH
- Parental history of Type 2 diabetes in patients with nonaffective psychosis
- (2007) Emilio Fernandez-Egea et al. SCHIZOPHRENIA RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started